Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-31

FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic's generic Nystatin and Triamcinolone Acetonide for topical treatment of candidal skin infections and inflammatory dermatoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nystatin and Triamcinolone Acetonide (Nystatin and Triamcinolone Acetonide)

Snippet

ORIG AP for NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)